Literature DB >> 17729037

Role of phosphoinositide 3-kinase signaling in autoimmunity.

Jean S Oak1, David A Fruman.   

Abstract

Activation of the phosphoinositide 3-kinase (PI3K) pathway promotes proliferation and survival in many different cell types of the immune system. PI3K acts downstream of receptors that mediate proliferation and survival in T cells, and required roles for individual class I PI3K catalytic isoforms have been established. Interestingly, mice with either augmented or diminished PI3K activity in T cells develop lymphoproliferation and signs of autoimmunity. Here, we summarize our current knowledge of mouse strains with hyperactive or reduced PI3K, different isoforms of class I PI3K in T cell-mediated immunity and autoimmunity, and the therapeutic implications for modulating this pathway for treatment of various autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729037     DOI: 10.1080/08916930701464780

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

1.  Effect of Sishen Pill on Memory T Cells From Experimental Colitis Induced by Dextran Sulfate Sodium.

Authors:  Wei Ge; Hai-Yan Wang; Hai-Mei Zhao; Xue-Ke Liu; You-Bao Zhong; Jian Long; Zheng-Yun Zuo; Duan-Yong Liu
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

2.  IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.

Authors:  Kenichiro Maeda; Harshini Mehta; Douglas A Drevets; K Mark Coggeshall
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

Review 3.  Identifying novel spatiotemporal regulators of innate immunity.

Authors:  Francisco Victorino; Scott Alper
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

4.  Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist.

Authors:  Thilipan Thaventhiran; Naif Alhumeed; Han X A Yeang; Swaminathan Sethu; Jocelyn S Downey; Ahmad F Alghanem; Adedamola Olayanju; Emma L Smith; Michael J Cross; Steven D Webb; Dominic P Williams; Adrian Bristow; Christina Ball; Richard Stebbings; Jean G Sathish
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

Review 5.  A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy.

Authors:  Qiong Xiang; Shuai Dong; Xian-Hui Li
Journal:  Med Sci Monit       Date:  2021-10-09

6.  Role of PI3K/Akt signaling in memory CD8 T cell differentiation.

Authors:  Eui Ho Kim; M Suresh
Journal:  Front Immunol       Date:  2013-02-01       Impact factor: 7.561

Review 7.  PI3K inhibitors are finally coming of age.

Authors:  Bart Vanhaesebroeck; Matthew W D Perry; Jennifer R Brown; Fabrice André; Klaus Okkenhaug
Journal:  Nat Rev Drug Discov       Date:  2021-06-14       Impact factor: 112.288

Review 8.  IL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells.

Authors:  Alaa Kassim Ali; Neethi Nandagopal; Seung-Hwan Lee
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.